Shijiazhuang Yiling Pharmaceutical

Shijiazhuang Yiling Pharmaceutical is one of the...

• CSI 300.

Shijiazhuang Yiling Pharmaceutical is a company listed under the stock ticker 002603 (CN).

View the org chart displaying its 13 main executives

Most searched biographies at Shijiazhuang Yiling Pharmaceutical

• Xiangjun Wu, General Manager
• Xiaohan Liu, Director
• Yiling Wu, Chairman of the Board

Create your alert
to follow the executive moves at Shijiazhuang Yiling Pharmaceutical.

Shijiazhuang Yiling Pharmaceutical has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Shijiazhuang Yiling Pharmaceutical

• News
• News

Social media about Shijiazhuang Yiling Pharmaceutical

• Shijiazhuang Yiling Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Shijiazhuang Yiling Pharmaceutical on LinkedIn, Twitter & YouTube

Contact by email its executives including Xiangjun Wu

Call Shijiazhuang Yiling Pharmaceutical at +86 311 ...

View the org chart

Register to receive your alert

Report an error